feed,title,long_url,short_url
Benzinga,Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder,https://benzinga.com/general/biotech/21/09/23114632/ultragenyx-resumes-dosing-antisense-trial-in-rare-neurogenetic-disorder,https://j.mp/3kKsT43
Benzinga,CEO And President Of Natera Trades $3.41 Million In Company Stock,https://benzinga.com/news/21/09/23114507/ceo-and-president-of-natera-trades-3-41-million-in-company-stock,https://j.mp/3iaZLBb
